SCHEMBL5808359

SCHEMBL5808359

COc1ccc(C(=O)/C=C/N(C)C)c(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.67
MAPT P10636 7/20 0.65
TNFRSF1A P19438 1/20 0.65
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
MAPK1 P28482 2/20 0.64
USP2 O75604 1/20 0.64
TLR9 Q9NR96 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.64
PDE4A P27815 1/20 0.63
PDE4B Q07343 1/20 0.63
PDE4C Q08493 1/20 0.63
PDE4D Q08499 1/20 0.63
NPC1 O15118 3/20 0.62
RAB9A P51151 2/20 0.62
ALDH1A1 P00352 1/20 0.60
HPGD P15428 1/20 0.60
XDH P47989 1/20 0.60
LMNA P02545 1/20 0.56
CYP1A1 P04798 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5808361 1.00 ABCG2 (0.67) ABCG2MAPTTNFRSF1AMEN1KMT2A
SCHEMBL12722743 1.00 ABCG2 (0.67) ABCG2MAPTTNFRSF1AMEN1KMT2A
SCHEMBL12722749 0.85 ABCG2 (0.65) ABCG2MAPTMEN1KMT2AMAPK1
SCHEMBL30904861 0.85 ABCG2 (0.65) ABCG2MAPTMEN1KMT2AMAPK1
SCHEMBL29690463 0.85 ABCG2 (0.65) ABCG2MAPTMEN1KMT2AMAPK1
SCHEMBL29246799 0.85 MAPT (0.60) ABCG2MAPTTNFRSF1AMEN1KMT2A
SCHEMBL2107582 0.85 ABCG2 (0.65) ABCG2MAPTMEN1KMT2AMAPK1
SCHEMBL2107584 0.85 ABCG2 (0.65) ABCG2MAPTMEN1KMT2AMAPK1
SCHEMBL24370751 0.84 GAA (0.62) ABCG2MAPTTNFRSF1AMEN1KMT2A
SCHEMBL6450819 0.84 GAA (0.62) ABCG2MAPTTNFRSF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006033795-A2 SUBSTITUTED PYRAZOLO [1, 5-A] PYRIMIDINES FOR INHIBITING ABNORMAL CELL GROWTH WYETH (US) 2006-03-30 WO disclosed
WO-2006033796-A1 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME WYETH (US) 2006-03-30 WO disclosed
US-20060063784-A1 Method of using substituted pyrazolo [1,5-a] pyrimidines WYETH 2006-03-23 US disclosed
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same WYETH 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063785-A1 Substituted pyrazolo[1,5-a] pyrimidines and process for making same TYMP, DPYD, TYMS ABCG2 419/4885MAPT 3174/4885TNFRSF1A 4436/4885
US-20060063784-A1 Method of using substituted pyrazolo [1,5-a] pyrimidines TYMP, DPYD, TYMS ABCG2 732/4885MAPT 4164/4885TNFRSF1A 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.